1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Lung Cancer Liquid Biopsy Market Size Growth Rate by Type: 2018 VS 2022 VS 2032
1.2.2 CTCs
1.2.3 CtDNA
1.2.4 Exosomes And RNA
1.2.5 Others
1.3 Market by Application
1.3.1 Global Lung Cancer Liquid Biopsy Market Share by Application: 2018 VS 2022 VS 2032
1.3.2 Clinics
1.3.3 Hospitals
1.3.4 Physicians' Office Laboratories
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Lung Cancer Liquid Biopsy Market Perspective (2018-2032)
2.2 Lung Cancer Liquid Biopsy Growth Trends by Region
2.2.1 Lung Cancer Liquid Biopsy Market Size by Region: 2018 VS 2022 VS 2032
2.2.2 Lung Cancer Liquid Biopsy Historic Market Size by Region (2018-2023)
2.2.3 Lung Cancer Liquid Biopsy Forecasted Market Size by Region (2023-2032)
2.3 Lung Cancer Liquid Biopsy Market Dynamics
2.3.1 Lung Cancer Liquid Biopsy Industry Trends
2.3.2 Lung Cancer Liquid Biopsy Market Drivers
2.3.3 Lung Cancer Liquid Biopsy Market Challenges
2.3.4 Lung Cancer Liquid Biopsy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Lung Cancer Liquid Biopsy Players by Revenue
3.1.1 Global Top Lung Cancer Liquid Biopsy Players by Revenue (2018-2023)
3.1.2 Global Lung Cancer Liquid Biopsy Revenue Market Share by Players (2018-2023)
3.2 Global Lung Cancer Liquid Biopsy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Lung Cancer Liquid Biopsy Revenue
3.4 Global Lung Cancer Liquid Biopsy Market Concentration Ratio
3.4.1 Global Lung Cancer Liquid Biopsy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Lung Cancer Liquid Biopsy Revenue in 2022
3.5 Lung Cancer Liquid Biopsy Key Players Head office and Area Served
3.6 Key Players Lung Cancer Liquid Biopsy Product Solution and Service
3.7 Date of Enter into Lung Cancer Liquid Biopsy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Lung Cancer Liquid Biopsy Breakdown Data by Type
4.1 Global Lung Cancer Liquid Biopsy Historic Market Size by Type (2018-2023)
4.2 Global Lung Cancer Liquid Biopsy Forecasted Market Size by Type (2023-2032)
5 Lung Cancer Liquid Biopsy Breakdown Data by Application
5.1 Global Lung Cancer Liquid Biopsy Historic Market Size by Application (2018-2023)
5.2 Global Lung Cancer Liquid Biopsy Forecasted Market Size by Application (2023-2032)
6 North America
6.1 North America Lung Cancer Liquid Biopsy Market Size (2018-2032)
6.2 North America Lung Cancer Liquid Biopsy Market Size by Country (2018-2023)
6.3 North America Lung Cancer Liquid Biopsy Market Size by Country (2023-2032)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Lung Cancer Liquid Biopsy Market Size (2018-2032)
7.2 Europe Lung Cancer Liquid Biopsy Market Size by Country (2018-2023)
7.3 Europe Lung Cancer Liquid Biopsy Market Size by Country (2023-2032)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Lung Cancer Liquid Biopsy Market Size (2018-2032)
8.2 Asia-Pacific Lung Cancer Liquid Biopsy Market Size by Country (2018-2023)
8.3 Asia-Pacific Lung Cancer Liquid Biopsy Market Size by Country (2023-2032)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Lung Cancer Liquid Biopsy Market Size (2018-2032)
9.2 Latin America Lung Cancer Liquid Biopsy Market Size by Country (2018-2023)
9.3 Latin America Lung Cancer Liquid Biopsy Market Size by Country (2023-2032)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Lung Cancer Liquid Biopsy Market Size (2018-2032)
10.2 Middle East & Africa Lung Cancer Liquid Biopsy Market Size by Country (2018-2023)
10.3 Middle East & Africa Lung Cancer Liquid Biopsy Market Size by Country (2023-2032)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Biocept
11.1.1 Biocept Company Detail
11.1.2 Biocept Business Overview
11.1.3 Biocept Lung Cancer Liquid Biopsy Introduction
11.1.4 Biocept Revenue in Lung Cancer Liquid Biopsy Business (2018-2023)
11.1.5 Biocept Recent Development
11.2 Exosome Diagnostics
11.2.1 Exosome Diagnostics Company Detail
11.2.2 Exosome Diagnostics Business Overview
11.2.3 Exosome Diagnostics Lung Cancer Liquid Biopsy Introduction
11.2.4 Exosome Diagnostics Revenue in Lung Cancer Liquid Biopsy Business (2018-2023)
11.2.5 Exosome Diagnostics Recent Development
11.3 F. Hoffmann-La Roche
11.3.1 F. Hoffmann-La Roche Company Detail
11.3.2 F. Hoffmann-La Roche Business Overview
11.3.3 F. Hoffmann-La Roche Lung Cancer Liquid Biopsy Introduction
11.3.4 F. Hoffmann-La Roche Revenue in Lung Cancer Liquid Biopsy Business (2018-2023)
11.3.5 F. Hoffmann-La Roche Recent Development
11.4 Qiagen
11.4.1 Qiagen Company Detail
11.4.2 Qiagen Business Overview
11.4.3 Qiagen Lung Cancer Liquid Biopsy Introduction
11.4.4 Qiagen Revenue in Lung Cancer Liquid Biopsy Business (2018-2023)
11.4.5 Qiagen Recent Development
11.5 Accuragen
11.5.1 Accuragen Company Detail
11.5.2 Accuragen Business Overview
11.5.3 Accuragen Lung Cancer Liquid Biopsy Introduction
11.5.4 Accuragen Revenue in Lung Cancer Liquid Biopsy Business (2018-2023)
11.5.5 Accuragen Recent Development
11.6 Agena Bioscience
11.6.1 Agena Bioscience Company Detail
11.6.2 Agena Bioscience Business Overview
11.6.3 Agena Bioscience Lung Cancer Liquid Biopsy Introduction
11.6.4 Agena Bioscience Revenue in Lung Cancer Liquid Biopsy Business (2018-2023)
11.6.5 Agena Bioscience Recent Development
11.7 Bard1
11.7.1 Bard1 Company Detail
11.7.2 Bard1 Business Overview
11.7.3 Bard1 Lung Cancer Liquid Biopsy Introduction
11.7.4 Bard1 Revenue in Lung Cancer Liquid Biopsy Business (2018-2023)
11.7.5 Bard1 Recent Development
11.8 Bgi
11.8.1 Bgi Company Detail
11.8.2 Bgi Business Overview
11.8.3 Bgi Lung Cancer Liquid Biopsy Introduction
11.8.4 Bgi Revenue in Lung Cancer Liquid Biopsy Business (2018-2023)
11.8.5 Bgi Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
